Standard Chem & Pharm Co Ltd
TWSE:1720
Standard Chem & Pharm Co Ltd
Cash & Cash Equivalents
Standard Chem & Pharm Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Cash & Cash Equivalents
NT$1.5B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
1%
|
CAGR 10-Years
11%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Cash & Cash Equivalents
NT$1.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Cash & Cash Equivalents
NT$1.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
25%
|
CAGR 10-Years
13%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Cash & Cash Equivalents
NT$4.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Cash & Cash Equivalents
NT$582.4m
|
CAGR 3-Years
21%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Cash & Cash Equivalents
NT$6B
|
CAGR 3-Years
55%
|
CAGR 5-Years
36%
|
CAGR 10-Years
19%
|
|
Standard Chem & Pharm Co Ltd
Glance View
Standard Chemical & Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese and western medicine, medicine raw materials, and health food. The company is headquartered in Tainan, Tainan. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The firm distributes its products both in domestic markets and overseas markets.
See Also
What is Standard Chem & Pharm Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.5B
TWD
Based on the financial report for Dec 31, 2024, Standard Chem & Pharm Co Ltd's Cash & Cash Equivalents amounts to 1.5B TWD.
What is Standard Chem & Pharm Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
11%
Over the last year, the Cash & Cash Equivalents growth was -25%. The average annual Cash & Cash Equivalents growth rates for Standard Chem & Pharm Co Ltd have been -16% over the past three years , 1% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet